tiprankstipranks
Trending News
More News >
Viridian Therapeutics (VRDN)
NASDAQ:VRDN
Advertisement

Viridian Therapeutics (VRDN) Revenue

Compare
1,423 Followers

Viridian Therapeutics Revenue

Viridian Therapeutics had a revenue of 70.57M in the quarter ending Sep 30, 2025, with 93993.33%. This bring the company's revenue in the last twelve months to 70.79M, Decreased 23109.51%. In the fiscal year ending Dec 31, 2024, Viridian Therapeutics had annual revenue of 302.00K with -3.82% growth.
Revenue (ttm)
70.79M
Revenue Growth
23340.07%
P/S Ratio
6951.15
Revenue/Employee
$2,112
Employees
143
Market Cap
$2.10B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
302.00K-12.00K+96.18%
Dec 31, 2023
314.00K-1.46M+17.72%
Dec 31, 2022
1.77M-1.19M+59.80%
Dec 31, 2021
2.96M1.91M+282.19%
Dec 31, 2020
1.05M-3.41M+23.54%
Dec 31, 2019
4.46M-3.92M+53.20%
Dec 31, 2018
8.39M4.38M+209.49%
Dec 31, 2017
4.00M666.00K+119.96%
Dec 31, 2016
3.34M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis